Polymeric controlled drug delivery

KW Leong, R Langer - Advanced Drug Delivery Reviews, 1988 - Elsevier
This contribution examines the current role that polymeric systems have in controlling the
administration and site-specific delivery of drugs. The fundamentals of polymeric controlled …

Levonorgestrel plasma concentrations and hormone profiles after insertion and after one year of treatment with a levonorgestrel-IUD

CG Nilsson, P Lähteenmäki, T Luukkainen - Contraception, 1980 - Elsevier
Plasma concentrations of levonorgestrel, progesterone, estradiol, FSH and LH were
measured in seven volunteers who had a levonorgestrel-releasing IUD inserted …

Controlled-release delivery systems for hormones: a review of their properties and current therapeutic use

LR Beck, VZ Pope - Drugs, 1984 - Springer
Biomedical engineering approaches used to develop controlled-release delivery systems for
hormones are here reviewed regarding system design and therapeutic applications. The …

Patterns of ovulation and bleeding with a low levonorgestrel-releasing intrauterine device

CG Nilsson, P Lähteenmäki, T Luukkainen - Contraception, 1980 - Elsevier
Patterns of bleeding and plasma concentrations of levonorgestrel, progesterone, estradiol,
LH and FSH were studied in ten volunteers who had a levonorgestrel-releasing IUD inserted …

Controlled release systems for contraception

HA Nash - Medical applications of controlled release, 2019 - taylorfrancis.com
Recognition of the sustained vigilance required for most methods of successful
contraception has stimulated attention to dosage forms that can deliver appropriate …

Pituitary and ovarian function and clinical performance during the use of a levonorgestrel-releasing intracervical contraceptive device

H Kurunmäki, J Toivonen, PLA Lähteenmäki… - Contraception, 1984 - Elsevier
A levonorgestrel-releasing intracervical device (ICD) was inserted postmenstrually to twenty-
one voluntary women. Eight subjects gave blood samples twice a week during the initial …

Contraception with subdermal ST-1435 capsules: side-effects, endocrine profiles and liver function related to different lengths of capsules

H Kurunmäki, J Toivonen, P Lähteenmäki… - Contraception, 1985 - Elsevier
One Silastik R capsule of 15 mm, 20 mm or 30 mm length was inserted subcutaneously into
the ventral aspect of the left forearm or upper arm of 28 healthy women during menstrual …

Intracervical release of ST-1435 for contraception

H Kurunmäki, J Toivonen, PLA Lähteenmäki… - Contraception, 1984 - Elsevier
Seven women used an ST-1435-releasing intracervical contraceptive device (ST-ICD),
inserted immediately after the cessation of menstrual bleeding. Patterns of bleeding and …

An oestrone-releasing vaginal ring in the treatment of climacteric women

S Sipinen, P Lahteenmaki, T Luukkainen - Maturitas, 1980 - Elsevier
Post-menopausal patients were treated with a new form of oestrogen administration by
using two types of oestrone-containing vaginal rings. It was observed that oestrone was …

Immediate postabortal contraception with NORPLANTR: Levonorgestrel, gonadotropin, estradiol, and progesterone levels over two postabortal months and return of …

H Kurunmäki, J Toivonen, PLA Lähteenmäki… - Contraception, 1984 - Elsevier
Six Silastic R levonorgestrel-releasing capsules, Norplant R, were introduced
subcutaneously into the ventral aspect of the left forearm or upper arm of thirteen patients …